Scrubcast podcast

Improving Cancer Immunotherapy with Dr. Alma Cepika

31/8/2026
0:00
20:19
Manda indietro di 15 secondi
Manda avanti di 15 secondi

On this episode of Scrubcast, Dr. Alma Cepika, assistant professor in the Division of General Surgery and chief of its new Surgical Sciences Section, explains how regulatory T cells help prevent the immune system from causing unnecessary damage. She introduces the differences between FOXP3 regulatory Tcells and type 1 regulatory T cells, or TR1 cells, and makes concepts such as multi-omics, transcription, epigenetics, and in vivo research accessible through everyday analogies.

The conversation explores her team’s research identifying TR1-like cells in human cancers and investigating whether these cells may suppress antitumor immunity or contribute to resistance to checkpoint inhibitor therapy. Dr. Cepika also discusses the complex role of TR1 cells in transplantation and persistentinfection.

Finally, she shares how advice from a movie helps her keep her calm, reveals her preference for punk rock in the lab, and describes opportunities for researchers and trainees to join her growing laboratory.


Link to article in Science Advances.


*Music by NastelBom*

Altri episodi di "Scrubcast"